Nath Bio-Genes (India) Limited (NATHBIOGEN.NS)
INR 167.42
(-0.32%)
INR 167.42
(-0.32%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.7 Billion INR | 23.08% |
| 2022 | 2.19 Billion INR | 9.85% |
| 2021 | 1.99 Billion INR | 13.45% |
| 2020 | 1.76 Billion INR | 2.26% |
| 2019 | 1.72 Billion INR | 24.44% |
| 2018 | 1.38 Billion INR | 35.8% |
| 2017 | 1.01 Billion INR | -32.81% |
| 2016 | 1.51 Billion INR | 4.38% |
| 2015 | 1.45 Billion INR | 22.17% |
| 2014 | 1.19 Billion INR | 10.04% |
| 2013 | 1.08 Billion INR | 7.28% |
| 2012 | 1 Billion INR | 35.81% |
| 2011 | 742.26 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.88 Billion INR | 130.86% |
| 2024 Q1 | -6.09 Billion INR | -325.64% |
| 2023 FY | 2.7 Billion INR | 23.08% |
| 2023 Q2 | 2.42 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 2.7 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 2.19 Billion INR | 9.85% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.66 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.19 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.22 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.99 Billion INR | 0.0% |
| 2021 FY | 1.99 Billion INR | 13.45% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 1.76 Billion INR | 2.26% |
| 2020 Q2 | 1.09 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 1.76 Billion INR | 0.0% |
| 2019 Q4 | 1.72 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 1.72 Billion INR | 24.44% |
| 2019 Q2 | 861.46 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 1.38 Billion INR | 35.8% |
| 2018 Q4 | 1.38 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 872.33 Million INR | 0.0% |
| 2017 Q1 | 1.31 Billion INR | -13.42% |
| 2017 FY | 1.01 Billion INR | -32.81% |
| 2017 Q4 | 1.01 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 1.34 Billion INR | 2.24% |
| 2016 Q1 | 1.42 Billion INR | -2.0% |
| 2016 FY | 1.51 Billion INR | 4.38% |
| 2016 Q4 | 1.51 Billion INR | 10.26% |
| 2016 Q3 | 1.37 Billion INR | 2.09% |
| 2016 Q2 | 1.34 Billion INR | -5.38% |
| 2015 Q2 | 962.81 Million INR | -36.13% |
| 2015 Q3 | 1.02 Billion INR | 6.38% |
| 2015 FY | 1.45 Billion INR | 22.17% |
| 2015 Q4 | 1.45 Billion INR | 41.96% |
| 2015 Q1 | 1.5 Billion INR | 26.67% |
| 2014 FY | 1.19 Billion INR | 10.04% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 1.19 Billion INR | 0.0% |
| 2013 FY | 1.08 Billion INR | 7.28% |
| 2013 Q4 | 1.08 Billion INR | 0.0% |
| 2012 FY | 1 Billion INR | 35.81% |
| 2012 Q4 | 1 Billion INR | 0.0% |
| 2011 FY | 742.26 Million INR | 0.0% |